DOTA

DOTA Basic information
Product Name:DOTA
Synonyms:TETRAAZA-12-CROWN-4 TETRAACETIC ACID AMMONIUM SALT (SEE 2923);Tetraxetan/radical;1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetrakisacetic acid;2,2',2'',2'''-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetryl)tetraacetic acid;2,2',2'',2'''-(1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetryl)tetrakisacetic acid;1,4,7,10-TETRAAZACYCLODODECANE-N,N'',N , N''-TETRAACETIC ACID , (DOTA);1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID DOTA;DOTA(M-140)
CAS:60239-18-1
MF:C16H28N4O8
MW:404.42
EINECS:611-959-5
Product Categories:Achiral Nitrogen;Cy-N;Azacrown Ethers;Functional Materials;Macrocycles for Host-Guest Chemistry;60239-18-1
Mol File:60239-18-1.mol
DOTA Structure
DOTA Chemical Properties
Melting point 267 °C
Boiling point 701.6±60.0 °C(Predicted)
density 1.321
storage temp. Sealed in dry,Room Temperature
solubility Water (Slightly, Heated), Methanol (Slightly)
pka2.16±0.10(Predicted)
form Powder
color white
BRN 1186987
Stability:Hygroscopic
Safety Information
Hazard Codes Xi
Risk Statements 36/37/38
Safety Statements 26-36
WGK Germany 3
3-10-34
HS Code 29339900
MSDS Information
ProviderLanguage
SigmaAldrich English
DOTA Usage And Synthesis
Chemical PropertiesColourless crystals
UsesBifunctional DOTA aconjugates to peptides and has become an established strategy for constructing target-specific metal containing agents including targeted MRI contrast agents and diagnostic and ther apeutic radiopharmaceuticals.
Uses1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) is a macrocyclic complexing agent.
  • It has been used for radiolabeling of carbon nanotube bioconjugates by chelating 64Cu radioisotope.
  • DOTA can be activated with N-hydroxysulfosuccinimidyl for conjugation with monoclonal antibodies in clinical radioimmunotherapy.
  • It can form complexes with gadolinium for application as MRI contrast agents.
  • Metal complexes of DOTA-peptide conjugates can be used as therapeutic radiopharmaceuticals.

DefinitionChEBI: An azamacrocyle in which four nitrogen atoms at positions 1, 4, 7 and 10 of a twelve-membered ring are each substituted with a carboxymethyl group.
octreotide, DOTA-Phe(1)- (DOTA(0)-Phe(1)-Tyr(3))octreotide 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 2-[(4-isothiocyanatophenyl)methyl]- indium 111-DOTA-lanreotide Nitrobenzyl DOTA DOTA-[TYR3]-OCTREOTATE,DOTA-[TYR3]-OCTREOTIDE ACID,DOTA-FCYWKTCT (DISULFIDE BRIDGE: 2-7),DOTA-D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR-OH (DISULFIDE BRIDGE: 2-7) TRI-TERT-BUTYL 1 4 7 10-TETRAAZACYCLODOD indium-111-DOTA-peptide chimeric L6 yttrium-90-DOTA-peptide-chimeric L6 gadolinium DOTA meglumine carboxymethyl-dextran-A2-gadolinium-DOTA polylysine-(Gd-DOTA) lead-203 DOTA-B72.3 DOTA-TRI-T-BU-ESTER,DOTA (OTBU)3 yttrium 90-DOTA-lanreotide DOTA-biotin dysprosium-DOTA-PAMAM Eu-DOTA,Europium DOTA

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.